MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Pesticide Exposure in PD with and without Genetic Risk Variants

E. Brown, C. Meng, S. Goldman, C. Tanner (San Francisco, CA, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 183

Keywords: Cognitive dysfunction, Environmental toxins

Category: Epidemiology

Objective: To evaluate the association between pesticide exposure and development of Parkinson’s disease (PD) in idiopathic and genetic PD, and to determine whether clinical features of PD in patients exposed to pesticides differ from people without.

Background: Many studies show an association between pesticide exposure and PD development, though how genetic risk variants modify these associations are still unclear. Additionally, the clinical features of PD are very different between patients, and the cause of this variability is not well understood.

Method: Participants in the Parkinson’s Progression Markers Initiative (PPMI) and Fox Insight (FI) cohorts provided information via an online survey about environmental risk factors. Phenotype was determined using MDS-UPDRS and MoCA scores in PPMI and baseline self-reported cognitive impairment (SCI) in FI.  We separated participants into idiopathic PD (iPD) or PD with a risk variant (either GBA or LRRK2). We used parametric and non-parametric tests as appropriate, adjusting for age and sex, as well as depression for SCI. We hypothesized that pesticide exposure would increase the risk of PD and be associated with a more severe phenotype.

Results: Responses were provided by 741 PPMI and 2,868 FI participants. In PPMI, occupational exposure to pesticide use was associated with a higher risk of developing idiopathic PD (adjusted OR = 3.90, 95% CI = 1.27 – 17.1, p = 0.034) though home exposure was not (aOR = 1.06, 95% CI = 0.525 – 2.07, p = 0.879). Among people with a GBA risk variant, pesticide exposure was associated with a higher risk of PD (aOR = 4.19, 95% CI = 1.09 – 18.4, p=0.047). This risk was still elevated but not significant in those with a LRRK2 variant (aOR = 1.38, 95% CI = 0.375 – 5.118, p = 0.62). In participants with idiopathic PD, there was a trend towards greater cognitive decline among those exposed to pesticides (MoCA change -1.44 vs + 0.299, p = 0.059). In FI, pesticides were associated with an increased risk of PD (aOR = 1.44, 95% CI = 1.01 – 2.12, p = 0.052). SCI was more likely in patients with a history of pesticide exposure (aOR = 1.51, 95% CI = 1.22 – 1.87, p < 0.001).

Conclusion: Pesticide use may increase the risk of PD in idiopathic and GBA-PD, and may also increase the risk of cognitive decline once PD develops.

To cite this abstract in AMA style:

E. Brown, C. Meng, S. Goldman, C. Tanner. Pesticide Exposure in PD with and without Genetic Risk Variants [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/pesticide-exposure-in-pd-with-and-without-genetic-risk-variants/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/pesticide-exposure-in-pd-with-and-without-genetic-risk-variants/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley